WHO ICTRP trial
Administration of liver and kidney protective agent
IRCT20250901067077N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20250901067077N1 |
|---|---|
| Public title | Administration of liver and kidney protective agent |
| Scientific title | The effect of intravenous administration of N-acetylcysteine during cardiopulmonary bypass on hepatic and renal function and cardiac enzymes in patients undergoing coronary artery bypass surgery |
| Primary sponsor | Pasture Institute of Iran |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Patients with coronary artery involvement.;I25.1 |
| Interventions | Intervention 1: Intervention group:Intervention group: Patients will be randomly divided into two groups receiving N-acetylcysteine ??and a control group. Patients in the receiving group will receive 100mg/kg N-acetylcysteine ??ampoule in… |
| Registration date | Oct 24, 2025 |
| Target size | 66 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: